Cargando…

HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy

BACKGROUND: HIV can infect multiple cells in the liver including hepatocytes, Kupffer cells and infiltrating T cells, but whether HIV can persist in the liver in people with HIV (PWH) on suppressive antiretroviral therapy (ART) remains unknown. METHODS: In a prospective longitudinal cohort of PWH an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zerbato, Jennifer M., Avihingsanon, Anchalee, Singh, Kasha P., Zhao, Wei, Deleage, Claire, Rosen, Elias, Cottrell, Mackenzie L., Rhodes, Ajantha, Dantanarayana, Ashanti, Tumpach, Carolin, Tennakoon, Surekha, Crane, Megan, Price, David J., Braat, Sabine, Mason, Hugh, Roche, Michael, Kashuba, Angela D.M., Revill, Peter A., Audsley, Jennifer, Lewin, Sharon R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763386/ https://www.ncbi.nlm.nih.gov/pubmed/36502576 http://dx.doi.org/10.1016/j.ebiom.2022.104391

Ejemplares similares

Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B co-infection
por: Singh, Kasha P., et al.
Publicado: (2020)

Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected Individuals
por: Wang, Xiao Qian, et al.
Publicado: (2022)

Diverse effects of interferon alpha on the establishment and reversal of HIV latency
por: Van der Sluis, Renée M., et al.
Publicado: (2020)

Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency
por: Zerbato, Jennifer M., et al.
Publicado: (2021)

Persistence of envelopes in different CD4(+) T-cell subsets in antiretroviral therapy-suppressed people with HIV
por: Gartner, Matthew J., et al.
Publicado: (2023)

Adaptation of Droplet Digital PCR-Based HIV Transcription Profiling to Digital PCR and Association of HIV Transcription and Total or Intact HIV DNA
por: Tumpach, Carolin, et al.
Publicado: (2023)

A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controls
por: McMahon, James H., et al.
Publicado: (2021)

Memory CD4(+) T cells that co-express PD1 and CTLA4 have reduced response to activating stimuli facilitating HIV latency
por: Rasmussen, Thomas A., et al.
Publicado: (2022)

Longitudinal analysis of subtype C envelope tropism for memory CD4(+) T cell subsets over the first 3 years of untreated HIV-1 infection
por: Gartner, Matthew J., et al.
Publicado: (2020)

No Difference in the Rate of Change in Telomere Length or Telomerase Activity in HIV-Infected Patients after Three Years of Darunavir/Ritonavir with and without Nucleoside Analogues in the MONET Trial
por: Solomon, Ajantha, et al.
Publicado: (2014)

Adaptation of the intact proviral DNA assay to a nanowell-based digital PCR platform
por: Tumpach, Carolin, et al.
Publicado: (2023)

Factors associated with weak positive SARS-CoV-2 diagnosis by reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR)
por: Rawat, Priyank, et al.
Publicado: (2022)

A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection
por: Kroon, Eugène D.M.B., et al.
Publicado: (2020)

Factors Associated with Elevated ALT in an International HIV/HBV Co-Infected Cohort on Long-Term HAART
por: Audsley, Jennifer, et al.
Publicado: (2011)

Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
por: Arandjelovic, Philip, et al.
Publicado: (2023)

Human Immunodeficiency Virus (HIV)–Infected CCR6(+) Rectal CD4(+) T Cells and HIV Persistence On Antiretroviral Therapy
por: Anderson, Jenny L, et al.
Publicado: (2020)

Rationale and clinical utility of the darunavir–cobicistat combination in the treatment of HIV/AIDS
por: Putcharoen, Opass, et al.
Publicado: (2015)

A Prediction Model of Pretreatment HIV RNA Levels in Naïve Thai HIV-infected Patients: An Application for Resource-limited Settings
por: Pongpech, Nisha, et al.
Publicado: (2017)

COVID-19 and HIV infection co-pandemics and their impact: a review of the literature
por: Gatechompol, Sivaporn, et al.
Publicado: (2021)

Challenges in Providing Treatment and Care for Viral Hepatitis among Individuals Co-Infected with HIV in Resource-Limited Settings
por: Maek-a-Nantawat, Wirach, et al.
Publicado: (2012)

348. Kidney Function Decline Among HIV-infected Thai Adults: Is Low Vitamin D One of the Factors?
por: Hlaing Than, Win, et al.
Publicado: (2019)

Response to Screening of diabetes mellitus among people living with HIV – a comment on “Diabetes mellitus burden among people living with HIV from the Asia‐Pacific region” (Han et al. 2019)
por: Han, Win M, et al.
Publicado: (2019)

HIV latency reversing agents act through Tat post translational modifications
por: Khoury, Georges, et al.
Publicado: (2018)

Risk factors of chronic hepatitis in antiretroviral-treated HIV infection, without hepatitis B or C viral infection
por: Chalermchai, Thep, et al.
Publicado: (2013)

Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection
por: Chuaypen, Natthaya, et al.
Publicado: (2023)

The Association of PNPLA3, COX-2 and DHCR7 Polymorphisms with Advanced Liver Fibrosis in Patients with HCV Mono-Infection and HCV/HIV Co-Infection
por: Kiatbumrung, Rattanaporn, et al.
Publicado: (2018)

Liver Fibrosis Regression Measured by Transient Elastography in Human Immunodeficiency Virus (HIV)-Hepatitis B Virus (HBV)-Coinfected Individuals on Long-Term HBV-Active Combination Antiretroviral Therapy
por: Audsley, Jennifer, et al.
Publicado: (2016)

Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand
por: Avihingsanon, Anchalee, et al.
Publicado: (2012)

Thymic plasmacytoid dendritic cells are susceptible to productive HIV-1 infection and efficiently transfer R5 HIV-1 to thymocytes in vitro
por: Evans, Vanessa A, et al.
Publicado: (2011)

HIV Infection and TLR Signalling in the Liver
por: Crane, Megan, et al.
Publicado: (2012)

An Integrated Approach to HIV Disclosure for HIV-Affected Families in Thailand
por: Jantarapakde, Jureeporn, et al.
Publicado: (2019)

Viral Rebound Kinetics Correlate with Distinct HIV Antibody Features
por: Bartsch, Yannic C., et al.
Publicado: (2021)

Comparable carotid intima-media thickness among long-term virologically suppressed individuals with HIV and those without HIV in Thailand
por: Putcharoen, Opass, et al.
Publicado: (2019)

Quantitative HBsAg and HBeAg Predict Hepatitis B Seroconversion after Initiation of HAART in HIV-HBV Coinfected Individuals
por: Matthews, Gail V., et al.
Publicado: (2013)

Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4
por: Fisher, Katie, et al.
Publicado: (2023)

HIV integration sites in latently infected cell lines: evidence of ongoing replication
por: Symons, Jori, et al.
Publicado: (2017)

Adherence and Risk Behaviour in Patients with HIV Infection Receiving Antiretroviral Therapy in Bangkok
por: Clarke, Amanda, et al.
Publicado: (2012)

Low-level genital HIV shedding in Thai HIV-infected women with suppressed plasma viral load after menopause: a longitudinal study
por: Landolt, Nadia Kancheva, et al.
Publicado: (2017)

Erratum to: HIV integration sites in latently infected cell lines: evidence of ongoing replication
por: Symons, Jori, et al.
Publicado: (2017)

The role of latency reversal in HIV cure strategies
por: Tanaka, Kiho, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cr1nmvg1upoajiumqrb4m1god3